COMBINED RADIOIMMUNOTHERAPY WITH RADIOTHERAPY

放射免疫治疗与放射治疗相结合

基本信息

  • 批准号:
    6350245
  • 负责人:
  • 金额:
    $ 15.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-04-01 至 2003-01-31
  • 项目状态:
    已结题

项目摘要

This grant application examines the hypothesis that radiolabeled antibody heterogeneity is the principal source of failure of radioimmunotherapy (RIT). It proposes that this limitation can be overcome by the combination of RIT with external beam radiotherapy (XRT). This study will investigate the interaction between XRT with RIT, and determine the optimum combination of these two modalities for maximum tumor efficacy. The hypothesis will be tested with the murine SW1222 colorectal xenograft model system using intact A33 IgG monoclonal antibody as the targeting agent and its single chain hypervariable sFv fragment. There are four specific aims: (1) To determine the 3D microdistribution of radiolabeled A33 IgG within the SW1222 tumor xenograft system using phosphor plate autoradiography. The dependence of the distribution will be investigated with respect of the antibody/antigen molar ratio, the effect of molecular weight, by concomitant administration of the single chain hypervariable fragment sFv A33 with the parent A33 IgG, and following pre-external beam irradiation. (2) To determine how radiation tissue damage facilitates/impedes the penetration of antibody into the tumor. This will be achieved by conventional histological and immunohistochemical stains designed to ascertain the effects of radiation damage on tumor blood supply, tumor cell density, as well as antigen density and inflammatory response. These changes will be used to provide a scientific rationale for the measured radiolabeled antibody distribution from specific aim 1. In addition, this aim will attempt to quantitate changes in tumor cell response by determining the fraction of cells undergoing apoptotic cell death, (by the tunel assay), as well as changes in the fraction of cycling cells, (determined by IUdR incorporation and Ki67 and PCNA immunohistochemistry), as a surrogate of mitotic cell death. (3) To determine the therapeutic efficacy by tumor growth delay and cure after treatment with XRT and RIT alone and then in combination. Experiments will be performed in which tumors are treated with XRT followed by RIT, XRT and RIT simultaneously, and RIT prior to XRT, in order to determine the optimum combination therapy. Variations in the tumor response will be correlated with the results from aim 1 and 2. (4) To develop a radiobiological model, which determines the therapeutic effectiveness from a heterogeneous activity distribution. The model will be tested using information from the source distribution from autoradiographic data (aim 1) to predict overall tumor response measured by specific aim 3.
这项拨款申请审查了放射性标记抗体异质性是放射免疫治疗(RIT)失败的主要原因的假设。 它提出,这一限制可以克服的RIT与外部束放射治疗(XRT)的组合。 本研究将研究XRT与RIT之间的相互作用,并确定这两种方式的最佳组合,以获得最大的肿瘤疗效。 将使用完整的A33 IgG单克隆抗体作为靶向剂及其单链高变sFv片段,使用鼠SW 1222结肠直肠异种移植模型系统来检验该假设。 有四个具体目标:(1)荧光板放射自显影法测定放射性标记的A33 IgG在SW 1222肿瘤异种移植系统中的三维微分布。 通过同时给予单链高变片段sFv A33和亲本A33 IgG,并在预外照射后,研究分布对抗体/抗原摩尔比、分子量的影响的依赖性。 (2)确定放射组织损伤如何促进/阻碍抗体渗透到肿瘤中。 这将通过常规组织学和免疫组织化学染色来实现,旨在确定辐射损伤对肿瘤血液供应、肿瘤细胞密度以及抗原密度和炎症反应的影响。这些变更将用于为特定目的1中测定的放射性标记抗体分布提供科学依据。 此外,该目标将试图通过确定经历凋亡性细胞死亡的细胞的分数(通过tunel测定)以及作为有丝分裂细胞死亡的替代物的循环细胞的分数的变化(通过IUdR掺入和Ki 67和PCNA免疫组织化学测定)来定量肿瘤细胞应答的变化。 (3)通过XRT和RIT单独或联合治疗后肿瘤生长延迟和治愈来确定疗效。将进行实验,其中肿瘤用XRT随后RIT、XRT和RIT同时治疗,以及RIT在XRT之前治疗,以确定最佳组合疗法。肿瘤缓解的变化将与目标1和2的结果相关。 (4)建立一个放射生物学模型,根据放射性分布的不均匀性确定治疗效果。 将使用来自放射自显影数据(目标1)的源分布信息对模型进行检验,以预测特定目标3测量的总体肿瘤缓解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN L HUMM其他文献

JOHN L HUMM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN L HUMM', 18)}}的其他基金

Targeting DNA Mismatches for Auger Electron Radiotherapy
针对 DNA 错配进行俄歇电子放射治疗
  • 批准号:
    10751210
  • 财政年份:
    2023
  • 资助金额:
    $ 15.7万
  • 项目类别:
Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer
胰腺癌放化疗中的影像学药物摄取和分布
  • 批准号:
    9185682
  • 财政年份:
    2016
  • 资助金额:
    $ 15.7万
  • 项目类别:
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer
124I-NaI PET:转移性甲状腺癌精准医疗的基石
  • 批准号:
    9976468
  • 财政年份:
    2016
  • 资助金额:
    $ 15.7万
  • 项目类别:
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer
124I-NaI PET:转移性甲状腺癌精准医疗的基石
  • 批准号:
    9326954
  • 财政年份:
    2016
  • 资助金额:
    $ 15.7万
  • 项目类别:
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer
124I-NaI PET:转移性甲状腺癌精准医疗的基石
  • 批准号:
    9176730
  • 财政年份:
    2016
  • 资助金额:
    $ 15.7万
  • 项目类别:
Detection of Tumor Hypoxia by Non-invasive Nuclear Imaging Methods
无创核成像方法检测肿瘤缺氧
  • 批准号:
    7102435
  • 财政年份:
    2006
  • 资助金额:
    $ 15.7万
  • 项目类别:
Quantitative Imaging: Biostatistics and Medical Physics
定量成像:生物统计学和医学物理
  • 批准号:
    8555299
  • 财政年份:
    2000
  • 资助金额:
    $ 15.7万
  • 项目类别:
COMBINED RADIOIMMUNOTHERAPY WITH RADIOTHERAPY
放射免疫治疗与放射治疗相结合
  • 批准号:
    6497663
  • 财政年份:
    1999
  • 资助金额:
    $ 15.7万
  • 项目类别:
COMBINED RADIOIMMUNOTHERAPY WITH RADIOTHERAPY
放射免疫治疗与放射治疗相结合
  • 批准号:
    2843985
  • 财政年份:
    1999
  • 资助金额:
    $ 15.7万
  • 项目类别:
COMBINED RADIOIMMUNOTHERAPY WITH RADIOTHERAPY
放射免疫治疗与放射治疗相结合
  • 批准号:
    6150259
  • 财政年份:
    1999
  • 资助金额:
    $ 15.7万
  • 项目类别:

相似海外基金

REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
  • 批准号:
    3056554
  • 财政年份:
    1990
  • 资助金额:
    $ 15.7万
  • 项目类别:
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
  • 批准号:
    3056556
  • 财政年份:
    1989
  • 资助金额:
    $ 15.7万
  • 项目类别:
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
  • 批准号:
    3056555
  • 财政年份:
    1988
  • 资助金额:
    $ 15.7万
  • 项目类别:
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
  • 批准号:
    3056553
  • 财政年份:
    1987
  • 资助金额:
    $ 15.7万
  • 项目类别:
The Athymic Mouse As a Model For the Study of Keloids
无胸腺小鼠作为瘢痕疙瘩研究的模型
  • 批准号:
    7816691
  • 财政年份:
    1978
  • 资助金额:
    $ 15.7万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了